A Phase II Trial of Capecitabine Rapidly Disintegrating Tablets and Concomitant Radiation Therapy in Children With Newly Diagnosed Brainstem Gliomas
Phase of Trial: Phase II
Latest Information Update: 23 Jul 2016
At a glance
- Drugs Capecitabine (Primary)
- Indications Glioma
- Focus Therapeutic Use
- Sponsors Roche
- 05 Feb 2014 According to ClinicalTrial.gov record, status changed from active, no longer recruiting to completed.
- 02 Dec 2013 Planned end date changed from 1 Jun 2013 to 1 Dec 2013 as reported by ClinicalTrials.gov.
- 15 Nov 2012 Planned end date changed from 1 Jun 2015 to 1 Jun 2013 as reported by ClinicalTrials.gov.